Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences


Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate at three upcoming investor conferences:

Citizens JMP Life Sciences Conference
Fireside Chat: Tuesday, May 14, 2024 at 1:30 p.m. Eastern Time in New York, NY

2024 RBC Capital Markets Global Healthcare Conference
Fireside Chat: Wednesday, May 15, 2024 at 11:30 a.m. Eastern Time in New York, NY

BofA Securities Health Care Conference
Fireside Chat: Wednesday, May 16, 2024 at 12:20 p.m. Eastern Time in Las Vegas, NV

Live webcasts of each fireside chat will be accessible on the company's website, Acadia.com, under the investors section and an archived recording will be available on the website for approximately one month following each presentation.

About Acadia Pharmaceuticals

Acadia is advancing breakthroughs in neuroscience to elevate life. For 30 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only FDA-approved drug to treat hallucinations and delusions associated with Parkinson's disease psychosis and the first and only FDA-approved drug for the treatment of Rett syndrome. Our clinical-stage development efforts are focused on Prader-Willi syndrome, Alzheimer's disease psychosis and multiple other programs targeting neuropsychiatric symptoms in central nervous system disorders. For more information, visit us at Acadia.com and follow us on LinkedIn and Twitter.


These press releases may also interest you

at 12:35
Imagining Combat Without Military Medicine: What Would That Look Like?
The Friends of the Uniformed Services University (Friends of USU) will host a lunch and panel discussion on Wednesday, May 22, 12:00-2:30 p.m. at the National Press Club in Washington, DC., to discuss the history, present state, and future of...

at 12:30
InventHelp Inventor Develops Improved Powered Toothbrush (BEC-361)
"As a dental hygienist, I wanted to create a new brushing tool to prevent soft tissue damage and gum recession," said an inventor, from Albuquerque, N.M., "so I invented the D S POWER BRUSH. My toothbrush head design would reduce the pain and...

at 12:30
Advanced Prenatal Therapeutics Receives Breakthrough Innovation Award at the California Investment Forum 2024
Advanced Prenatal Therapeutics, Inc. ("APT") is pleased to have received the California Investment Forum (CIF) 2024 Innovation Award for Breakthrough Medical Technology in Diagnosis and Treatment in recognition of APT's breakthrough technology, the...

at 12:22
Novel non-addictive, non-toxic painkiller developed at LSU Health New Orleans
LSU Health New Orleans announces the discovery and clinical advancement of a new non-opioid therapeutic candidate for treatment of acute, chronic, and neuropathic pain and migraine headaches which does not have the organ toxicity or addiction...

at 12:20
PTC Therapeutics Announces European Commission Returns Translarnatm Opinion to CHMP For Re-evaluation
PTC Therapeutics, Inc. announced today that the European Commission (EC) has decided not to adopt the CHMP's negative opinion of Jan. 24, 2024, on the annual renewal of the conditional marketing authorization of Translarnatm (ataluren) and has...

at 12:20
Resurgia Health Solutions and Ennoble Care's Georgia Housecalls Practice Finalize Combination to Strengthen Healthcare Access in Georgia
Resurgia Health Solutions and Ennoble Care have united to strengthen healthcare access in Georgia. With no change in leadership, the merged practice will ensure continuity of care while providing more density, responsiveness, and resources to meet...

More news about Health...


News published on and distributed by: